Stemrecht
Per 31 december 2024 bezit de Vereniging 284.282.445 gewone aandelen Aegon Ltd. en 345.442.360 gewone aandelen B Aegon Ltd. zijnde 31,3892 % van de aandelen Aegon Ltd.
Het onder normale omstandigheden door de Vereniging uit te oefenen stemrecht op de gewone aandelen en de gewone aandelen B, berekend op basis van het aantal uitstaande stemgerechtigde aandelen (exclusief de door Aegon Ltd. ingekochte eigen aandelen), bedroeg per 31 december 2024 ongeveer 18,39% (31 december 2023 ongeveer 18,46%).
In het geval dat zich een ”bijzondere aanleiding” voordoet, kan het stemrecht van de Vereniging voor de duur van maximaal zes maanden worden uitgeoefend voor het volledige aantal beschikbare stemmen, dat per 31 december 2024 31,3892% bedroeg (31 december 2023: 32,75%). Het stemrecht in geval zich een bijzondere aanleiding voordoet is onder alle omstandigheden gemaximaliseerd tot 32,64%.
Stemverslagen 2022- 2025
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2.4 | Approval of the final dividend 2024 | vóór |
| 3.1 | Proposal to appoint Ernst & Young Accountants LLP as independent auditor for the 2026 financial year | vóór |
| 4.1 | Re-election of Mr. William Connelly as member of the Board of Directors | vóór |
| 4.2 | Re-election of Mr. Mark Ellman as member of the Board of Directors | vóór |
| 4.3 | Re-election of Mr. Jack MacGarry as member of the Board of Directors | vóór |
| 4.4 | Election of Ms. Lori Fouché as member of the Board of Directors | vóór |
| 4.5 | Election of Mr. David Herzog as member of the Board of Directors | vóór |
| 4.6 | Election of Mr. Jay Ralph as member of the Board of Directors | vóór |
| 5.1 | Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with an issuance of common shares of less than 10% of the Company’s issued share capital | vóór |
| 5.2 | Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with a rights issue in excess of 10% of the Company’s issued share capital | vóór |
| 7.3 | Authorization of the Board of Directors to acquire shares in the Company | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2.2 | Remuneration Report 2023 | vóór |
| 2.3 | Approval of the final dividend 2023 | vóór |
| 3.1 | Adoption of the Directors’ Remuneration Policy | vóór |
| 4.1 | Proposal to appoint Ernst & Young Accountants LLP as independent auditor for the 2025 financial year | vóór |
| 5.1 | Proposal to approve the amended Bye-laws of Aegon Ltd | vóór |
| 6.1 | Re-election of Mr. Lard Friese as member of the Board of Directors | vóór |
| 6.2 | Re-election of Ms. Corien Wortmann-Kool as member of the Board of Directors | vóór |
| 6.3 | Re-election of Ms. Caroline Ramsay as member of the Board of Directors | vóór |
| 6.4 | Re-election of Mr. Thomas Wellauer as member of the Board of Directors | vóór |
| 6.5 | Election of Mr. Albert Benchimol as member of the Board of Directors | vóór |
| 7.1 | Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with issuance of common shares | vóór |
| 7.2 | Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with a rights issue | vóór |
| 7.3 | Authorization of the Board of Directors to acquire shares in the Company | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2 | Decision (i) to change the jurisdiction and the nationality of the Company from the Grand Duchy of Luxembourg to Bermuda, and to transfer the registered office of the Company from the Grand Duchy of Luxembourg to Bermuda (the "Bermuda Conversion"), effective at the issuance of the certificate of continuance by the Registrar of Companies of Bermuda (the "Bermuda Migration Effective Time"), (ii) to change the name of the Company from "Aegon S.A." to "Aegon Ltd.", effective at the Bermuda Migration Effective Date, (iii) to approve the memorandum of continuance of the Company which shall be deemed to be the memorandum of association of the Company and to adopt the bye-laws of the Company (the "Bye-laws") replacing the current articles of association of the Company in their entirety, effective at the Bermuda Migration Effective Date, and (iv) to grant powers of attorney. | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2.1 | Proposal to enter into the cross-border conversion to Luxembourg and to amend the Articles of Association to reflect the conversion into a Luxembourg S.A. | vóór |
| 3.1 | Appointment of William Connelly | vóór |
| 3.2 | Appointment of Mark Ellman | vóór |
| 3.3 | Appointment of Karen Fawcett | vóór |
| 3.4 | Appointment of Jack McGarry | vóór |
| 3.5 | Appointment of Caroline Ramsay | vóór |
| 3.6 | Appointment of Thomas Wellauer | vóór |
| 3.7 | Appointment of Corien Wortmann-Kool | vóór |
| 3.8 | Appointment of Dona Young | vóór |
| 3.9 | Appointment of Lard Friese | vóór |
| 4.1 | Appointment independent auditor Aegon S.A | vóór |
| 4.2 | Appointment independent auditor Aegon Ltd. for the 2023 financial year | vóór |
| 4.3 | Appointment independent auditor Aegon Ltd. for the 2024 financial year | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2.2 | Remuneration Report 2022 | adviserende stem vóór |
| 2.4 | Adoption of the Annual Accounts 2022 | vóór |
| 2.5 | Approval of the final dividend 2022 | vóór |
| 3.1 | Release from liability for the members of the Executive Board for their duties performed during 2022 | vóór |
| 3.2 | Release from liability for the members of the Supervisory Board for their duties performed during 2022 | vóór |
| 4.1 | Proposal to appoint Ernst & Young Accountants LLP as independent auditor for the Annual Accounts of 2024 through 2028 | vóór |
| 5.1 | Reappointment of Ms. Dona Young as member of the Supervisory Board | vóór |
| 6.1 | Proposal to cancel common shares and common shares B | vóór |
| 6.2 | Authorization of the Executive Board to issue common shares with or without pre-emptive rights | vóór |
| 6.3 | Authorization of the Executive Board to issue shares in connection with a rights issue | vóór |
| 6.4 | Authorization of the Executive Board to acquire shares in the Company | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 3 | Approval of the Transaction | vóór |
| Agendapunt | Voorstel | Stem |
|---|---|---|
| 2.2 | Remuneration Report 2021 | adviserende stem vóór |
| 2.3 | Adoption of the Annual Accounts 2021 | vóór |
| 2.4 | Approval of the final dividend 2021 | vóór |
| 3.1 | Release from liability for the members of the Executive Board for their duties performed during 2021 | vóór |
| 3.2 | Release from liability for the members of the Supervisory Board for their duties performed during 2021 | vóór |
| 4.2 | Reappointment of Ms. Corien Wortmann-Kool as member of the Supervisory Board | vóór |
| 4.3 | Appointment of Ms. Karen Fawcett as member of the Supervisory Board | vóór |
| 5.1 | Proposal to cancel common shares and common shares B | vóór |
| 5.2 | Authorization of the Executive Board to issue common shares with or without pre-emptive rights | vóór |
| 5.3 | Authorization of the Executive Board to issue shares in connection with a rights issue | vóór |
| 5.4 | Authorization of the Executive Board to acquire shares in the Company | vóór |